- Report
- March 2024
- 186 Pages
Global
From €3210EUR$3,374USD£2,734GBP
€3567EUR$3,749USD£3,038GBP
- Report
- March 2024
- 190 Pages
Global
From €3210EUR$3,374USD£2,734GBP
€3567EUR$3,749USD£3,038GBP
- Report
- November 2023
- 175 Pages
Global
From €4757EUR$5,000USD£4,052GBP
- Report
- June 2024
- 359 Pages
Global
From €5185EUR$5,450USD£4,417GBP
- Report
- March 2024
- 199 Pages
Global
From €3210EUR$3,374USD£2,734GBP
€3567EUR$3,749USD£3,038GBP
- Report
- September 2023
- 145 Pages
Global
From €2378EUR$2,499USD£2,025GBP
- Report
- February 2024
- 110 Pages
Global
From €4519EUR$4,750USD£3,850GBP
- Report
- March 2024
- 188 Pages
Global
From €3210EUR$3,374USD£2,734GBP
€3567EUR$3,749USD£3,038GBP
- Report
- March 2024
- 196 Pages
Global
From €3210EUR$3,374USD£2,734GBP
€3567EUR$3,749USD£3,038GBP
- Report
- March 2024
- 196 Pages
Global
From €3210EUR$3,374USD£2,734GBP
€3567EUR$3,749USD£3,038GBP
- Report
- March 2024
- 185 Pages
Global
From €3210EUR$3,374USD£2,734GBP
€3567EUR$3,749USD£3,038GBP
- Report
- August 2023
- 240 Pages
Global
From €1893EUR$1,990USD£1,613GBP
- Report
- February 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,052GBP
- Report
- February 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,052GBP
- Report
- February 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,052GBP
- Report
- January 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,052GBP
- Report
- February 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,052GBP
- Report
- September 2023
- 149 Pages
Global
From €2378EUR$2,499USD£2,025GBP
- Report
- June 2024
- 89 Pages
Global
From €5328EUR$5,600USD£4,538GBP
- Report
- June 2024
- 288 Pages
Global
From €5328EUR$5,600USD£4,538GBP
The Lung Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat lung cancer. These drugs are used to treat both non-small cell and small cell lung cancer, the two most common types of lung cancer. The drugs are designed to target the cancer cells and stop them from growing and spreading. Common treatments include chemotherapy, targeted therapy, immunotherapy, and radiation therapy.
The Lung Cancer Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies such as Bristol-Myers Squibb, Merck, Pfizer, AstraZeneca, and Roche are all major players in the market. These companies are constantly researching and developing new drugs to treat lung cancer, as well as improving existing treatments.
In addition, there are many smaller companies that specialize in the development of new drugs for the treatment of lung cancer. These companies often collaborate with larger pharmaceutical companies to bring their drugs to market. Examples of these companies include ImmunoGen, Inc., Oncolytics Biotech, and ImmunoCellular Therapeutics. Show Less Read more